Multimodal therapy concepts in oesophageal carcinoma: Importance of radio- and chemotherapy;Multimodale behandlungskonzepte beim osophaguskarzinom: Stellenwert der radio- und chemotherapie

Schweizerische Medizinische Wochenschrift

Volumn 129, Issue 34, 1999, Pages 1224-1229

  Thum, P ^a   Frey, E ^a   Schefer, H ^a  

^a LUZERNER KANTONSSPITAL   (Switzerland)

Author keywords

Combined modality therapy; Multimodal therapy; Neoadjurant chemotherapy; Oesophageal cancer

Indexed keywords

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; ESOPHAGUS CARCINOMA; HUMAN; MULTIMODALITY CANCER THERAPY;

ANTINEOPLASTIC AGENTS; CISPLATIN; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; HUMANS; SURVIVAL RATE;

EID: 0033612940     PISSN: 00367672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Blot WJ. Esophageal cancer trends and risk factors. Semin Oncol 1994;21:403.
2. Blot WJ, Devesa SS, Fraumeni JF Jr. Continuing climb in rates of esophageal adenocarcinoma: an update [letter]. JAMA 1993;270:1320.
3. Munoz N, Day NE. Esophageal cancer. In: Schottenfeld D, Fraumeni J Jr, editors. Cancer Epidemiology and Prevention. 2nd ed. New York: Oxford University Press; 1996. p. 681-706.
4. Lagergren J, Bergström R, Lindgren A, Nyrén O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999;340:825-31.
5. Wobst A, Audisio RA, Colleoni M, Geraghty JG. Esophageal cancer treatment: studies, strategies and facts. Ann Oncol 1998;9:951-62.
6. Fritz P, Wannenmacher M. Die Strahlenbehandlung in der multimodalen Therapie des Ösophaguskarzinoms. Strahlenther Onkol 1997;173:295-308.
7. Teniere P, Hay JM, Fingerhut A, Fagniez PL. Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. Surg Gynecol Obstet 1991;173:123-30.
8. Fok M, Sham JST, Choy D, Cheng SW, Wong J. Postoperative radiotherapy for carcinoma of the esophagus: a prospective, randomized controlled study. Surgery 1993;113: 138-47.
9. Zieren HU, Mueller JM, Jacobi CA, Pichelmaier H, Müller RP, Staar S. Adjuvant postoperative radiation therapy after curative resection of squamous cell cardinoma of the thoracic esophagus: a prospective randomized study. World J Surg 1995;19:444-9.
10. Arnott SJ, Duncan W, Kerr GR, Walbaum PR, Cameron E, Jack WJL, et al. Low-dose preoperative radiotherapy for carcinoma of the esophagus: results of a randomized clinical trial. Radiother Oncol 1992;24:108-13.
11. Gignoux M, Roussel A, Paillot B, Gillet M, Schlag P, Favre JP, et al. The value of preoperative radiotherapy in esophageal cancer: results of a study of the EORTC. World J Surg 1987;11:426.
12. Wang M, Gu XZ, Yin WB, Huang G, Wang LJ, Zhang DW. Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of esophageal carcinoma: Report on 206 patients. Int J Radiat Oncol Biol Phys 1989;16:325.
13. Launois B, Delarue D, Campion JP, Kerbaol M. Preoperative radiotherapy for carcinoma of the esophagus. Surg Gynecol Obstet 1981;153:690-2.
14. Ajani JA. Contributions of chemotherapy in the treatment of carcinoma of the esophagus: results and commentary. Semin Oncol 1994;21:474-82.
15. Ajani JA, Ilson DH, Daugherty K, Pazdur R, Lynch PM, Kelsen DP. Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus. J Natl Cancer Inst 1994;86:1086-91.
16. Conroy T, Etienne P, Adenis A, Wagener DJ, Paillot B, Francois E, et al. Phase II trial of vinorelbine in metastatic squamous cell esophageal carcinoma. J Clin Oncol 1996; 14:164-70.
17. Ajani JA, Ilson D, Bhalla K, Forastiere A, Pazdur R, Martin L, et al. Taxol, Cisplatin and 5-FU: a multi-institutional phase II study in patients with carcinoma of the esophagus. Proc Am Soc Clin Oncol 1995;14:203a.
18. Kelsen DP, Ginsberg R, Pajak TF, Sheahan DG, Gunderson L, Mortimer J, et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 1998;339:1979-84.
19. Maipang T, Vasinanukorn P, Petpichetchian C, Chamroonkul S, Geater A, Chansawwaeng S, et al. Induction chemotherapy in the treatment of patients with carcinoma of the esophagus. J Surg Oncol 1994;56:191-7.
20. Schlag P. Randomized study of preoperative chemotherapy in squamous cell cancer of the esophagus. CAO Esophageal Cancer Study Group. Arch Surg 1992;127:1446-50.
21. Roth JA, Pass HI, Flanagan MM, Graeber GM, Rosenberg JC, Steinberg S. Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus, J Thorac Cardiovasc Surg 1988;96:242-8.
22. Herskovic A, Martz K, Al-Sarraf M, Leichman L, Brindle JS, Vaitkevicius V, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992;326:1593-8.
23. Al-Sarraf M, Martz K, Herskovic A, Leichman L, Brindle JS, Vaitkevicius V, et al. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol 1997; 15:277-84.
24. Smith TJ, Ryan LM, Douglass HO, Haller DG, Yogeshwar D, Kirkwood J, et al. Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: a study of the Eastern Cooperative Oncology Group. Int J Radiat Oncol Biol Phys 1998;42:269-76.
25. Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TPJ. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996; 335:462-7.
26. Urba S, Orringer M, Turrisi A, Whyte R, Lannettoni M, Forastiere A. A randomized trial comparing surgery (S) to preoperative concomitant chemoradiation plus surgery in patients (pts) with resectable esophageal cancer (CA): updated analysis. Proc Am Soc Clin Oncol 1997;337:277a.
27. Bosset JF, Gignoux M, Triboulet JP, Tiret E, Mantion G, Elias D, et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous cell cancer of the esophagus. N Engl J Med 1997;337:161-7.
28. Le Prise E, Etienne P, Meunier B, Maddern G, Ben Hassel M, Gedouin D, et al. A randomized study of chemotherapy, radiation therapy and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 1994; 73:1779-84.